Ideaya Biosciences Stock In The News
| IDYA Stock | USD 18.25 0.14 0.76% |
Our overall analysis of Ideaya Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Ideaya Biosciences. The specific impact of Ideaya Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ideaya Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ideaya Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ideaya Biosciences Backtesting and Ideaya Biosciences Hype Analysis. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ideaya and other traded companies coverage with news coverage. We help investors stay connected with Ideaya headlines for the 24th of March to make an informed investment decision based on correlating the impacts of news items on Ideaya Stock performance. Please note that trading solely based on the Ideaya Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ideaya |
Ideaya Biosciences Today Top News and Investor Outlook
Ideaya Biosciences Past News Timeline
Ideaya Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ideaya earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ideaya Biosciences that are available to investors today. That information is available publicly through Ideaya media outlets and privately through word of mouth or via Ideaya internal channels. However, regardless of the origin, that massive amount of Ideaya data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ideaya Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ideaya Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ideaya Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ideaya Biosciences alpha.
Ideaya Largest EPS Surprises
Earnings surprises can significantly impact Ideaya Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-02-20 | 2023-12-31 | -0.47 | -0.52 | -0.05 | 10 | ||
2022-05-10 | 2022-03-31 | -0.41 | -0.36 | 0.05 | 12 | ||
2023-08-10 | 2023-06-30 | -0.56 | -0.5 | 0.06 | 10 | ||
2023-05-09 | 2023-03-31 | -0.55 | -0.49 | 0.06 | 10 | ||
2023-03-07 | 2022-12-31 | -0.56 | -0.5 | 0.06 | 10 | ||
2021-03-23 | 2020-12-31 | -0.3 | -0.18 | 0.12 | 40 |
Ideaya Biosciences Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ideaya Biosciences Stock. Current markets are strongly bearish. About 79% of major world exchanges and indexes are down. See today's market update for more information.
11th of March 2025
Ideaya Biosciences stock hits 52-week low at 17.28 - Investing.com at news.google.com
3rd of March 2025
IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AIML-Enabled Drug Dis... at finance.yahoo.com
28th of February 2025
IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635 at gurufocus.com
18th of February 2025
Disposition of 12808 shares by Yujiro Hata of Ideaya Biosciences at 19.52 subject to Rule ... at MacroaxisInsider
13th of February 2025
IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combinati... at finance.yahoo.com
11th of February 2025
Sage Therapeutics, Inc. Reports Q4 Loss, Lags Revenue Estimates at zacks.com
10th of February 2025
All You Need to Know About IDEAYA Biosciences Rating Upgrade to Buy at zacks.com
31st of January 2025
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635 at finance.yahoo.com
3rd of January 2025
We Think IDEAYA Biosciences Can Afford To Drive Business Growth at simplywall.st
Ideaya Biosciences Investors Sentiment
The influence of Ideaya Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ideaya. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ideaya Biosciences' public news can be used to forecast risks associated with an investment in Ideaya. The trend in average sentiment can be used to explain how an investor holding Ideaya can time the market purely based on public headlines and social activities around Ideaya Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ideaya Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ideaya Biosciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ideaya Biosciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ideaya Biosciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ideaya Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ideaya Biosciences' short interest history, or implied volatility extrapolated from Ideaya Biosciences options trading.
Check out Ideaya Biosciences Backtesting and Ideaya Biosciences Hype Analysis. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.36) | Revenue Per Share | Quarterly Revenue Growth 0.785 | Return On Assets | Return On Equity |
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.